))
Episode 3: DMHA and Phenibut - Warning Letters
Manage episode 311560501 series 3142400
Content provided by PerforMax Labs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PerforMax Labs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
The FDA has sent 11 companies (so far) for marketing dietary supplements that don’t meet its "guidelines".
The agency issued warnings to three companies for marketing dietary supplements containing phenibut, which is sometimes sold as a sleep aid or to treat anxiety. It said that phenibut doesn’t meet the statutory definition of a dietary ingredient, which is generally a vitamin, herb or other natural substance used to supplement the diet.
These products are considered adulterated because the FDA has determined that DMHA is either a “new dietary ingredient” for which the FDA has not received the required New Dietary Ingredient notification or that DMHA is an unsafe food additive.
But is it REALLY?
12 episodes
Share
